Skip to main content

Table 1 Disease-specific comorbidities and CCI of HK patients

From: The burden of hyperkalemia in Germany – a real world evidence study assessing the treatment and costs of hyperkalemia

Disease (ICD-10-GM code)

Non-acute outpatient treated HK patients

N = 3333

Chronic HK patients

N = 1693

n

%

n

%

CKD

 CKD stages 1 to 5 (N18.1 + N18.2 + N18.3 + N18.4 + N18.5)

1737

52.1

860

50.8

 CKD stage 3 to 5 (N18.3 + N18.4 + N18.5)

1623

48.7

805

47.5

HF

 Heart failure (ANY) (I50.11-I50.14, I50.19)

681

20.4

320

18.9

T2DM

 Diabetes mellitus, type 2 (E11.-)

1481

46.44

753

44.5

Comorbidities (CKD, T2DM, HF)

None

943

28.3

483

28.5

One Comorbidity

1203

36.1

633

37.4

 CKD

640

19.2

331

19.6

 T2DM

486

14.6

264

15.6

 HF

77

2.3

38

2.2

Two Comorbidities

865

26.0

431

25.5

 CKD + T2DM

583

17.5

295

17.4

 CKD + HF

192

5.8

88

5.2

 T2DM + HF

90

2.7

48

2.8

Three Comorbidities

322

9.7

146

8.6

≥ One Comorbidity

2390

71.7

1210

71.5

Charlson Comorbidity Index (CCI)

CCI score: 0

397

11.9

185

10.9

CCI score: 1

502

15.1

283

16.7

CCI score: 2

485

14.6

247

14.6

CCI score: 3

494

14.8

265

15.7

CCI score: ≥4

1455

43.7

713

42.1

Mean CCI score

3.32

3.26